Organizational influences on innovation to improve quality in health care by Brewster, Amanda Lauren
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2015
Organizational influences on
innovation to improve quality in
health care
https://hdl.handle.net/2144/13652
Boston University
	  BOSTON UNIVERSITY 
 
SCHOOL OF PUBLIC HEALTH 
 
 
 
 
 
Dissertation 
 
 
 
 
 
ORGANIZATIONAL INFLUENCES ON INNOVATION 
 
TO IMPROVE QUALITY IN HEALTH CARE 
 
 
 
 
by 
 
 
 
 
AMANDA BREWSTER 
 
B.S., Yale University, 2003 
M.Sc., London School of Economics and Political Science, 2006 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Doctor of Philosophy 
 
2015  
	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2015 by 
 AMANDA BREWSTER 
 All rights reserved  
	  Approved by 
 
 
First Reader _________________________________________________________ 
 Martin P. Charns, DBA 
 Professor of Health Policy & Management 
 
 
 
 
Second Reader _________________________________________________________ 
 James F. Burgess, Ph.D. 
 Professor of Health Policy & Management 
 
 
 
 
Third Reader _________________________________________________________ 
 Elizabeth Bradley, Ph.D., MBA 
 Professor of Public Health (Health Policy) 
 Yale University 
 
 
 
 
Fourth Reader _________________________________________________________ 
 Shoshanna Sofaer, Dr.P.H. 
 Director of Strategic Research Planning for Health Policy Research 
 American Institutes for Research 
 
 
 
 
Fifth Reader _________________________________________________________ 
 Kelly J. Devers, Ph.D. 
 Senior Fellow 
 Urban Institute 
	  	  iv 
DEDICATION 
 
 
 
 
I would like to dedicate this work to my family:  my husband Joseph Shapiro and parents 
Kathy and Marty Brewster, who supported me from the beginning of my PhD, and my 
sons Simon Shapiro and Isaac Shapiro, who joined along the way. 
 
  
	  	  v 
ACKNOWLEDGMENTS 
I would like to thank my dissertation committee of Martin Charns, James Burgess 
and Elizabeth Bradley for their wisdom, guidance and encouragement throughout my 
dissertation research. I also benefitted from the expertise of outstanding co-authors during 
the research and writing process. Co-authors of the paper that constitutes Chapters Two 
are:  Emily Cherlin, Chima Ndumele, Diane Collins, James Burgess, Martin Charns, 
Elizabeth Bradley, and Leslie Curry. Co-authors of the paper that constitutes Chapter 
Three are:  Leslie Curry, Emily Cherlin, Kristina Talbert-Slagle, Leora Horwitz, and 
Elizabeth Bradley.  
 
  
	  	  vi 
ORGANIZATIONAL INFLUENCES ON INNOVATION 
TO IMPROVE QUALITY IN HEALTH CARE 
AMANDA BREWSTER 
Boston University School of Public Health, 2015 
Major Professor: Martin P. Charns, DBA, Professor of Health Policy & Management 
 
ABSTRACT 
 With medical evidence constantly advancing, the health care system faces 
pressure to generate, apply and integrate innovations to improve the quality of patient 
care. This dissertation examines how organizational characteristics influence these 
processes. 
 The first study, a systematic review, investigates how organizational features 
influence the translation of basic research findings to clinical applications. Results 
showed a dearth of peer-reviewed literature on this topic, despite a proliferation of efforts 
to accelerate translational research by manipulating organizational structures and 
processes. Few studies effectively linked structures, processes and outcomes and no 
organizational feature was associated conclusively with translation of research into 
clinical practice. 
 The second study draws on in-depth qualitative interviews (82 participants at 10 
hospitals) to understand how hospitals that reduced readmission rates had applied 
innovations in clinical practice and organizational context. High performing and low 
performing hospitals had both implemented similar clinical practice changes in their 
efforts to reduce readmissions; however, high performing hospitals reported greater 
	  	  vii 
investment in creating an organizational context to facilitate readmissions. This included 
more extensive efforts to improve collaboration within the hospital, greater coordination 
between the hospital and outside providers, deeper engagement in learning and problem 
solving related to readmissions, and greater senior leadership support.  
 The third study draws on an expanded set of interviews from the same data 
collection (90 participants at 10 hospitals) to investigate mechanisms through which 
innovations become integrated into hospital routines. Despite a well-developed literature 
on the initial implementation of new practices, we have limited knowledge about the 
mechanisms by which integration occurs. Results showed that when an innovation was 
integrated successfully, a small number of key staff held the innovation in place for as 
long as a year while more permanent integrating mechanisms began to work. Innovations 
that proved intrinsically rewarding to staff integrated through shifts in attitudes and 
norms over time. Innovations that did not provide direct benefits to staff were integrated 
through changed incentives or automation. 
 Together, these studies illuminate opportunities for hospitals to improve patient 
care by managing the organizational context in which innovations are deployed. 
Understanding how organizational context affects translation requires further research. 
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CHAPTER ONE. ORGANIZATIONAL FEATURES THAT INFLUENCE 
BENCH-TO-BEDSIDE TRANSLATIONAL RESEARCH WITHIN ACADEMIC 
MEDICAL CENTERS:  SYSTEMATIC LITERATURE REVIEW 
 
INTRODUCTION 
In recent years, the perception that basic science is moving fast – with 
breakthroughs in human genomics, stem cell biology, biomedical engineering, molecular 
biology and immunology – has sharpened concern that the translation of these scientific 
advances into clinical applications is a rate limiting step for the improvement of health. A 
2003 study found that out of 101 new technologies described in highly-cited basic 
science journals between 1979 and 1983 as having clinical applications, only 5 were 
eventually licensed for clinical use, and only one went on to be widely used [1].  In 
considering how to improve the development of new clinical interventions from 
underlying scientific advances, health research leaders have used the concept of 
translational research to describe the processes requiring improvement [2]. The definition 
of translational research remains broad, but generally means working across traditional 
disciplines and functional domains, with the goal of developing clinical applications from 
scientific discoveries. The attempts to improve the performance of translational research 
implicitly recognize that the development and adoption of a good idea is not inevitable, 
but depends upon the right social and organizational context being in place. 
In an attempt to optimize the institutional and organizational environments for 
encouraging translational research, major biomedical research funders such as the NIH 
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have launched special initiatives on translational research. The NIH Clinical 
Translational Science Awards (CTSA) program, announced in 2005 as part of the NIH 
Roadmap Initiative, is among the largest of these, involving close to $500 million per 
year in NIH funding [3]. According to NIH, the CTSA program was launched to “create 
academic homes for clinical and translational research” [4]. The establishment of the NIH 
National Center for Advancing Translational Sciences in December 2011 underscored the 
priority placed on translational research. 
 Designing institutional homes to improve clinical and translational research 
requires knowing what institutional features facilitate this complex activity. To some 
extent, scientists and clinicians have a sense for what works based on personal 
experiences, and editorials, commentaries and case studies have emphasized the need for 
collaboration and interchange across disciplines [5–12], which is also reflected in the 
CTSA goals [4]. Certain barriers to translational research are also consistently identified, 
including research workforce issues (e.g., lack of qualified investigators, career 
disincentives), research operations issues (e.g., lack of funds, regulatory burden, 
fragmented infrastructure) and organizational silos (e.g., barriers to collaboration among 
basic scientists and clinicians) [10, 13]. However, little empirical evidence exists to link 
organizational structures or processes and translational research outcomes. To help define 
this gap, we conducted a systematic review of peer reviewed publications reporting 
empirical findings related to the institutional or organizational factors that influence the 
success of T1 (or “bench to bedside”) translational research in academic medical settings. 
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Scope of review: Institutional or organizational factors influencing success of T1 
translational research 
As attention to translational research has increased, its taxonomy has grown and 
now by some accounts encompasses four distinct stages, summarized in Table 1.1 [14–
17]. Due to the heterogeneity of organizations and activities involved across these four 
stages, the present paper focuses exclusively on investigating the first stage of 
translational research (T1), the development of basic scientific discoveries into early-
stage health interventions that can be provided to humans. Later stages of translation, 
such as securing widespread adoption of new interventions into evidence-based clinical 
practice or healthcare policy, are considered outside of our scope. 
Table 1.1. Four stages of translational research. 
Stage Description Example 
T1 Development of new clinical 
interventions that may improve 
human health  
Basic research approaching application in 
humans, animal studies, phase I and phase 
II clinical trials 
T2 Development of evidence-based 
guidelines for use in health practice 
Phase III and phase IV clinical trials, meta-
analysis, observational studies to establish 
guidelines 
T3 Implementation of evidence-based 
practice in clinical practice 
Implementation research to explore 
barriers and facilitators to using the 
intervention in standard care 
T4 Population-level approaches to 
encourage availability of evidence-
based practice 
Policy studies to investigate adoption of 
new practice nationwide 
 
The core function of the T1 stage is connecting a basic scientific discovery with a 
clinical application – that is, traversing or integrating the domains of basic scientific 
research, clinical practice and applied technology development. The events of the T1 
stage have also been referred to as taking a discovery from “bench to bedside” [15]. 
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Effectively negotiating this scientific pathway depends not only on solving scientific 
problems, but also relies upon social and organizational processes. We have limited the 
scope of our systematic review to studies that analyze systematically collected data to 
examine the role of organizational or institutional features on the process of the T1 stage 
of translational research. We included peer reviewed studies that addressed this question 
using any research methodology. 
METHODS 
Literature Search 
We used the PubMed database to search for articles published any time before 
October 2014. After identifying an initial set of articles through keyword searches and 
browsing relevant journals, we developed a comprehensive search strategy. It should be 
noted that the widespread use of the term “translational research” in publications 
reporting findings of translational research studies themselves (as opposed to findings 
about the organizational or institutional processes involved) made it infeasible to use this 
as a stand-alone search term. A 2014 PubMed search for articles containing “translational 
research” in any article field returned 92,812, with particularly rapid growth in the past 
10 years and 9,719 articles published in 2013 (Figure 1.1). To focus our search on the 
most relevant articles, we limited our keyword search to the article title, and used the 
following main search terms: “Translational research”, “Translational science,” and 
“Translation of research.” We further focused the search by retaining only the articles 
that contained at least one of a set of secondary search terms related to organizational or 
institutional processes. The secondary search terms were selected through a process of 
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brainstorming, assembling an initial set of articles, and then adding further secondary 
terms mentioned in the initial articles. The final PubMed search string was as follows:  
((translational research or translational science or translation of research) and (collaborat* 
or communicat* or coordinat* or cross-disciplinary or cross-functional or culture or 
entrepreneur* or faculty or form or incentive or institution* or interdisciplinary or 
leadership or multidisciplinary or organization* or rewards or support)). This search 
identified 62 unique articles.  
Figure 1.1.  PubMed Results for “Translational Research.” 
 
Titles and abstracts of all articles retrieved from the PubMed search were 
reviewed. Articles were excluded if they were: (1) not in English, or (2) outside of the 
scope of our study. Articles falling outside of our scope typically reported results of a 
translational study (e.g., “Characterization and comparison of Standard" and "Young" 
tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational 
Research Institution”), or described information technology / database systems (e.g., 
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“Research electronic data capture (REDCap)--a metadata-driven methodology and 
workflow process for providing translational research informatics support”).  
The references of each of the retained articles were reviewed by hand and those 
with potentially relevant titles were retrieved. Google Scholar was used to review 
forward citations and articles with potentially relevant titles were retrieved. These articles 
were reviewed and the process of screening references and forward citations was 
continued iteratively until no new articles were identified. A total of 77 articles were 
identified in through references and forward citations.  
All articles meeting the eligibility criteria for topical relevance were read. 
Empirical studies that documented methods and data were retained, while editorials and 
descriptive reports (e.g., personal reflections, narrative case studies, etc.) were excluded. 
A total of 22 articles were retained in the final sample (Figure 1.2 illustrates the process). 
Figure 1.2. Search Process. 
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Data Analysis 
The articles retrieved were heterogeneous in terms of methodology, level of 
analysis, and focus. To facilitate consideration of this disparate body of literature, we 
drew upon a framework widely used for the analysis of health care quality [18]. This 
framework groups factors contributing to an end goal (in our case, T1 translation) 
according to whether they pertain to organizational structure (e.g., how personnel were 
organized into units within the organization, general characteristics of the organization’s 
members), processes (e.g., collaboration among personnel, use of infrastructure), or 
outcomes (e.g., desired end products of translational research such as therapies, drugs, 
etc.). We also categorized the articles according to methodology and the unit of analysis 
(e.g., institutions, individuals, or discoveries/ technologies). The 22 retained articles were 
re-read to systematically extract this information. 
RESULTS 
A total of 139 articles were gathered from PubMed searches, references and 
forward citations and 22 articles met our study’s inclusion criteria of reporting empirical 
evidence on the topic of organizational or institutional factors that influence T1 
translational research. Table 1.2 provides details of the 22 included articles and Table 
1.3 summarizes characteristics of the set of articles. 
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Table 1.2. Characteristics of studies that met inclusion criteria. 
Author Level of analysis Level of analysis: detail 
Unit of 
analysis Unit of analysis: detail Method 
Berro et al. (2011) [19] Structure Presence of clinical trials support office Institution 24 CTSA institutions Survey 
Bian et al. (2014) [20] 
Structure Existence of CTSA 
Institution Faculty at a single CTSA awardees institution 
Analysis of 
administrative 
data; Network 
analysis 
Process Collaboration 
Brassil et al. (2014) [21] Process 
How navigation program for researchers 
affected approval of human research 
protocols 
Institution Users of university’s protocol navigation service 
Analysis of 
administrative 
data 
Contopoulos-Ioannidis, 
Ntzani, and Ioannidis 
(2003) [1] 
Structure Industry involvement Discovery/ 
Technology 
101 basic research articles 
published 1979-83 promising 
clinical application 
Bibliometrics 
Outcome Whether discoveries led to new therapies 
Douglas et al. (2014) 
[22] 
Structure Links between producer and user organizations 
Institution Research network established to study immunity Qualitative Process Collaboration 
Outcome Development of technology and clinical applications 
Feldman et al. (2012) 
[23] Process 
Participation in translational science 
mentor program; self-reported attitudes Individual 
Faculty participating in mentor 
training program at a single 
university 
Survey 
Harris et al. (2012) [24] Structure 
Characteristics of organizational 
networks Institution 18 research institutions in Arizona 
Survey; 
Network 
analysis Process Collaboration 
Heller and de Melo-
Martin (2009) [13] Structure 
Organizational features introduced to 
promote T.R. in CTSA proposals Institution 
12 initial CTSA awardee 
institutions 
Analysis of 
administrative 
data 
Heller and Michelassi 
(2012) [25] 
Structure Personnel characteristics Institution Department-level reports on collaboration  Survey Process Collaboration 
Hughes, Peeler, and 
Hogenesch (2010) [26] 
Structure Establishment of CTSA 
Individual Faculty at a single CTSA awardee institution 
Bibliometrics; 
Network 
analysis Process Collaboration 
Hughes et al. (2014) [27] Structure Multi-institution research network Individual Faculty at 27 Alzheimer’s disease Bibliometrics; 
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Process Collaboration research centers at US universities 
Network 
analysis 
Hunt, Whipple, and 
McGowan (2012) [28] Process utilization of CTSA infrastructure Individual 
Use of CTSA infrastructure by 
faculty members at a single 
institution 
Analysis of 
administrative 
data; 
Bibliometrics 
Knowlton (2013) [29] Process 
How participation in translational 
research training program affected 
student attitudes 
Individual Students at a single institution Survey 
Lander and Atkinson-
Grosjean (2011) [30] 
Structure Personnel characteristics 
Individual Members of a research team Qualitative Process 
iterative movement back and forth 
between lab and clinic 
Outcome clinical identification of new genetic disease 
Long et al. (2014) [31] 
Structure Location and professional affiliation 
Individual 52 researchers in a translational research network 
Survey; 
Network 
analysis Process Collaboration 
Luo, Zheng, and 
Bhavani (2010) [32] 
Process Collaboration Individual 15 researchers at one institution Qualitative   
Martin, Brown, and 
Kraft (2008) [33] 
Process Iterative movement back and forth between lab and clinic Discovery/ Technology 
hematopoietic stem cell 
technology Qualitative Outcome hematopoietic stem cell technology 
Morgan et al. (2011) 
[34] 
Structure Culture and translational research infrastructure Individual 24 researchers at one UK university hospital Qualitative Process perceptions and practices around T.R. infrastructure 
Nagarajan, Kalinka, and 
Hogan (2012) [35] Process Collaboration Individual 
Faculty at a single CTSA 
awardee institution 
Analysis of 
administrative 
data; Network 
analysis 
Wainwright et al. (2006) 
[36] 
Structure Culture Individual Members of a single research laboratory in UK Qualitative Process Presentation of one's research as T.R. 
Weston et al. (2010) [37] Structure Personnel Characteristics Individual faculty members at single institution Survey Process Collaboration 
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Outcome Self-reported involvement in translational research (T.R.) 
Zinner and Campbell 
(2009)[38] 
Structure Personnel characteristics 
Individual Faculty across 50 medical schools Survey 
Process funding and activities 
Outcome self-reported involvement with phase I clinical trials 
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Table 1.3. Summary of article characteristics. 
	  
*Note:  Percentages do not add up to 100% in Level of Analysis and Method because the same 
article could have more than one 
 
Processes assumed to facilitate translational research represented the most 
common level of analysis (86%); nearly half of articles retrieved in our review examined 
the process of collaboration. Other processes analyzed included utilization of 
infrastructure that had been introduced for translational research and researchers’ 
attitudes about translational research. Structural features were also examined in a large 
proportion (73%) of the studies. Structural features included the existence of certain 
organizational elements (e.g., a CTSA), characteristics of organizations (e.g., geographic 
location, industry or university sector) and characteristics of the personnel that composed 
an organization (e.g., professional qualifications). Relatively few studies (27%) included 
data about the desired outcomes of translational research, such as therapies or clinical 
applications. 
Feature No. (%)* 
Level of Analysis 
 Structure 16 (73%) 
 Process 19 (86%) 
 Outcome 6 (27%) 
Unit of Analysis 
 Institution 7 (32%) 
 Individual 13 (59%) 
 Discovery/ technology 2 (9%) 
Method 
 Analysis of administrative data 5 (23%) 
 Bibliometrics 4 (18%) 
 Network analysis 6 (27%) 
 Survey 8 (36%) 
 Qualitative 6 (27%) 
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 The unit of analysis considered by most studies (59%) was the individual 
researcher, although 32% of studies reported analysis at the level of institution and 9% of 
studies reported analysis of specific discoveries or technologies. About three-quarters of 
the studies relied on quantitative methods, using data from surveys, administrative data, 
or bibliometrics. Just over one-quarter of the studies used these data sources to analyze 
networks of collaboration. Qualitative methods were used by 27% of studies. Half of the 
qualitative studies involved data on outcomes of translational research whereas less than 
20% of quantitative studies involved data on outcomes. Generalizability of the studies 
reviewed was limited by the fact that most (60%) included data from only a single 
institution. Another common methodological challenge, affecting many of the studies that 
examined the impact of structural changes on processes, was the lack of an adequate 
comparison group to control for secular change over time.  
Overall, we found the available literature about the influence of organizational 
and institutional factors on T1 translational research to be limited in quantity and 
heterogeneous in quality. Still, reviewing the extant literature provides a helpful overview 
of structural and process factors that have been identified by researchers as potentially 
important to translational research outcomes; we review these factors below.  
Structural influences on T1 translational research 
Structural influences examined in the literature included professional culture [34, 
36], organizational units such as CTSAs or research networks [13, 20, 26, 27, 34], offices 
specialized in supporting particular steps of translational research [19], the personnel 
available to conduct translational research [25, 31, 37, 38], and the types of organizations 
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involved in a research project [1, 22]. 
Professional Culture 
Wainwright et al. (2006) provide an insightful account of how government and 
funders’ rhetorical and policy emphasis on translational research – in this study, the 
potential for embryonic stem cell research to cure many diseases – influence how basic 
scientists feel they must frame their work [36]. Basic scientists interviewed for this 
qualitative study understood the need to communicate about their work in terms of 
clinical applications, despite considering such applications unlikely. While it is not clear 
if the perceived pressure to emphasize clinical applications affected scientists’ actual 
work, the need to promise unlikely clinical applications might alter the apparent success 
rate of translational research.  
The study by Wainwright et al. (2006) also identified cultural differences between 
the domains of basic science and clinical science, though the authors note that 
participants offered “performative” accounts of the differences among these 
communities. Interviewees reported sharply divergent cultures while “standing above this 
professional divide,” demonstrating an ability to consider it objectively and possibly 
surmount it. Morgan et al. (2011) also found differences between the professional 
cultures of basic scientists and clinical scientists which made basic scientists less 
receptive to the a program designed to encourage translational research [34]. The 
translational research program was modeled on industry practices, with such elements as 
“go/ no-go” milestones at which a project might be cut short if it was not showing desired 
results. Basic scientists perceived the process as conflicting with their perception of 
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legitimate science and misaligned with their career incentives. Clinical scientists, with a 
more applied orientation, were more receptive to the translational research program.  
Organizational features 
The available studies do not present strong causal evidence linking particular 
organizational structures with processes or outcomes of translational research. Heller and 
de Melo Martin (2009) analyzed successful CTSA proposals and found that the proposed 
centers sought to address barriers related to research workforce and research operations - 
such as establishing training programs and improving regulatory, bioinformatics and pilot 
funding programs ([13]. Broader institutional barriers such as such as department-based 
promotions and budgeting, and the high costs of translational research, were not 
addressed by the CTSA centers, leading the authors to speculate that CTSA centers may 
have difficulty improving translational research. However, the study did not present data 
on how the proposed centers were implemented. 
Hughes, Peeler, and Hogenesh (2010) and Bian et al. (2014) both attempt to link a 
structural change, the establishment of a CTSA, to translational research processes – with 
collaboration used as a proxy for translational research [20, 26]. Both studies report 
stronger networks of collaboration after establishment of a CTSA but only [26] included 
matched controls (faculty at the same institution who were not affiliated with the CTSA) 
to account for secular trends. 
Harris et al. (2012) and Hughes et al. (2014) both assess the impact of inter-
organizational research networks on collaboration [24, 27]. Hughes et al. (2014) reported 
increased collaboration among participants in an Alzheimer’s disease research network 
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over its 25 years of existence, although the lack of a comparison group allows for the 
possibility of a secular trend toward collaboration [27]. Harris et al. (2012) surveyed 18 
Arizona cancer research organizations to elucidate inter-organizational networks of 
collaboration, funding one development-oriented institution to be a central node in 
collaboration networks for discovery, development and delivery research [24]. Although 
the authors suggest that this highlights the centrality of the development work, the small 
size of the study and limited data collection (only one respondent from each institution 
reported on collaborations) makes it difficult to generalize from the results. 
Berro et al. (2011) surveyed the 24 CTSA recipient institutions active in 2008 to 
ascertain the presence of a particular type of structure: an office to support investigators 
through the process of fulfilling the regulatory requirements of clinical trials [19]. The 
authors found that 55% of respondent institutions had established such an office, and 
these offices performed functions such as training, assistance with regulatory 
submissions, and preparation for audits. However, the study did not connect the existence 
of these structures to changes in the processes around clinical trials or improved research 
outcomes.  
Personnel 
Two surveys of faculty reported covariates of respondents’ involvement in translational 
research, providing some insight into the characteristics of personnel required for 
translational research [37, 38]. In a survey of Johns Hopkins University faculty, Weston 
et al. (2010), found that MDs and MD/PhDs were significantly more likely to report 
translational research than PhDs, and junior and senior faculty were significantly more 
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likely to report translational research than postdoctoral fellows [37]. A survey of faculty 
across 50 medical schools by Zinner and Campbell (2009) found a connection between 
conducting translational research and holding an MD or MD-PhD, and also found that 
translational researchers were more likely to have industry funding [38]. Qualitative work 
by [30] also supports the importance of the clinician-scientist role. 
Surveys assessing personnel features associated with collaboration found that researchers 
who are geographically close and professionally similar are more likely to collaborate 
[31] and suggest that the role of degree qualification in predicting collaboration varies by 
context [25]. Within departments of surgery, Heller and Michelassi (2012) found that 
81% of PhDs were engaged in interdepartmental collaboration whereas only 27% of MDs 
and MD-PhDs were.  
Types of organizations involved in research project 
 Both Contopoulous-Ioannidis, Ntzani, and Ioannidis (2003) and Douglas et al. 
(2014) provide results suggesting that translational research is facilitated by involvement 
of both academic and applied sectors in a research project [1, 22]. Douglas et al. (2014) 
report results of a qualitative study highlighting the importance of reciprocal interchange 
between producers (basic scientists) and users (technologists, industry or clinicians) in 
the pathway to translational research products.  
Processes influencing translational research 
The most commonly studied process related to translational research was 
collaboration among researchers [20, 22, 24–27, 31, 32, 35, 37]. Other processes studied 
included the movement of translational projects between the domains of basic science 
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and clinical medicine [30, 33], utilization of services intended to promote translational 
research [21, 28, 34] and completion of training related to translational research [23, 29].  
Collaboration 
As described in the previous section, four articles used collaboration as a proxy 
outcome to measure the impact of structural changes intended to encourage translational 
research [20, 24, 26, 27]. Despite this, we only identified one study that explicitly 
examined the association between collaboration and translational research. This study, 
which measured faculty self-identification as translational researchers, did support a link 
as faculty identifying themselves as translational researchers reported more collaborators 
than faculty that did not [37] although all respondents came from a single university. Two 
studies examined the dynamics of collaboration among individuals identified as 
translational researchers [32, 35] without seeking to link the process of collaboration to 
structures or outcomes or translational research.  
Movement between lab and clinic 
The importance of the process of iterative movement between lab and clinic 
through the course of translational research was emphasized in two qualitative studies 
[30, 33]. Martin, Brown, and Kraft (2008) reported how a long chain of interaction 
between clinical experience and laboratory studies were involved in the development of 
haematopoetic stem cells for clinical applications. Lander and Atkinson-Grosjean (2011) 
reported how the clinical identification of a previously unrecognized genetic disease led 
scientists to reinterpret the prevailing understanding of a particular element of the 
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immune system, which eventually led to the development of a genetic test for the newly 
identified condition.  
Utilization of services 
Studies examining utilization of specific services intended to facilitate 
translational research were able to provide limited information on the effectiveness of 
these services. Hunt, Whipple, and McGowan (2012) found that services provided by a 
CTSA were utilized by a substantial number of researchers but this does not necessarily 
imply that the services helped those researchers [28]. Brassil et al. (2014) showed that 
users of a service to facilitate preparation and review of human research protocols had 
high rates of protocol approval and appeared to become more proficient at the process but 
the study lacked a comparison group [21]. A qualitative study of a program to encourage 
translational research within a UK hospital found that the researchers involved had 
complex reactions to the goals and components of the program, highlighting the fact that 
simply adding new structures or processes to the research environment will not 
necessarily facilitate translational research [34].  
Training 
Two studies reported results of training programs intended to foster translational 
research. Feldman et al. (2012) found that participants in a translational research mentor 
training program reported that it improved their skills [23]. Knowlton et al. (2013) found 
that predoctoral students participating in a translational research educational program 
reported higher levels of self-efficacy for translational research on some but not other 
measures [29].   
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Outcomes used to measure translational research 
 Only three studies attempted to measure translational research as a quantitative 
outcome [1, 37, 38] and two of these studies relied on self-reported involvement in 
translational research [37, 38]. Only one quantitative study [1] tried to measure 
translational research outcomes in terms of actual technologies developed and used in 
clinical practice. A further three studies [22, 30, 33] reported qualitatively on clinical 
technologies developed through translational research. 
DISCUSSION 
The results of our systematic review of literature on the topic of institutional and 
organizational factors influencing translational research revealed a surprising dearth of 
evidence on this topic, despite a proliferation of efforts to accelerate translational 
research by manipulating organizational structures and processes. Collaboration appears 
to be the topic most frequently studied in relation to translational research, as an assumed 
prerequisite, despite little empirical evidence linking collaboration to translational 
research outcomes. Very few studies attempt to link structures or processes to actual 
technologies applied in clinical practice, likely due to the extremely long lag times that 
can exist between initial discovery and clinical application. Given the difficulty of 
measuring outcomes of translational research directly, further research to validate process 
measures linked to translational research may be useful. While collaboration among 
researchers seems to have high face validity as a proxy for translational research, greater 
understanding of what features of collaborations are most closely associated with 
translational research success would be helpful. 
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Although a number of studies examined the association between structural 
features and processes or outcomes thought to represent translational research, it is 
notable that the interpersonal dynamics and culture of research organizations received 
attention only in studies employing qualitative methods. Given the evidence that 
organizational culture plays an instrumental role in innovation and performance in other 
institutional settings such as health care services [39–45] and manufacturing [46, 47], it 
seems that more systematic study of the relationship between organizational culture and 
translational research is warranted. Mixed methods approaches [48–50] deployed to 
understand the role of culture and context in other institutional settings might be fruitfully 
applied to this end. 
Our study is affected by several limitations. First, the extremely frequent use of 
the term “translational research” in publications unrelated to our focal topic meant that 
we needed to impose a variety of additional constraints in our database search strategy. 
These limits in the initial search may have prevented us from identifying some relevant 
articles, although our iterative review of references and forward citations allowed us to 
identify many more relevant articles beyond the initial database search. Second, we 
limited our search to peer-reviewed articles; therefore we may have missed articles in the 
gray literature. A broader scan including gray literature may be able to identify additional 
important evidence, particularly if evaluations related to the CTSA program are not being 
published in the peer-reviewed literature. Finally, limitations in the quantity and scope of 
the articles identified through our systematic review prevent us from drawing any robust 
conclusions about how institutional and organizational features affect T1 translational 
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research.  
In conclusion, our review of the extant literature on institutional and 
organizational factors that affect T1 translational research demonstrates a need for further 
research on this topic. Most of the studies attempting to assess the role of organizational 
structures or processes involve only a single institution, limiting generalizability. At this 
time, the most illuminating empirical studies on the organizational and institutional 
factors that influence translational research are qualitative studies [30, 33, 36] but these 
studies generate rather than test hypotheses. As the CTSA interventions mature, perhaps 
further mixed methods studies will be able to test some of these hypotheses. 
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CHAPTER TWO. WHAT WORKS IN READMISSIONS REDUCTION: 
HOW HOSPITALS IMPROVE PERFORMANCE 
 
INTRODUCTION 
With more than three quarters of eligible hospitals receiving penalties for their 30-
day readmission rates [51], hospitals across the U.S. are actively seeking to reduce 
avoidable readmissions [52]. Nevertheless, the evidence on how best to accomplish this 
goal is mixed [53–55]. Controlled trials [56–62] and cross-sectional studies [63–65] have 
identified different practices that may be effective, such as patient education, discharge 
planning, and telephone follow up; however, no specific clinical practice has been shown 
to consistently reduce readmissions [55]. Furthermore, longitudinal studies have failed to 
link specific hospital practices with subsequent reduction in risk standardized 
readmission rates (RSRRs), although employment of a greater number of these practices 
seems to be helpful [53].  
Several studies of hospital quality have suggested that the organizational context 
in which strategies are undertaken, beyond the strategies themselves, may be critical in 
distinguishing higher and lower performing institutions [39, 41–43, 66–68]. These studies 
have linked dimensions of organizational context such as communication, coordination, 
and leadership to high performance for a range of outcomes such as mortality after acute 
myocardial infarction (AMI) [42, 43, 66], surgical outcomes [39, 67, 68], and patient 
satisfaction [41]. Few, if any, studies have examined the role of organizational context in 
hospital RSRR performance.  
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 Accordingly, we undertook an in-depth examination of efforts to reduce 
readmissions among a set of hospitals in which RSRR performance had notably improved 
or deteriorated. We sought to understand how high performing hospitals achieved 
documented improvements, and whether their changes at the level of clinical practice and 
organizational context may have differed from low performing hospitals [50]. The 
hospitals were selected from participants in the State Action on Avoidable 
Rehospitalizations (STAAR) initiative, a quality improvement collaborative that operated 
from 2009-2013 in Massachusetts, Michigan and Washington [69]. Thus, we anticipated 
that all hospitals had made some effort to reduce readmissions, although trends in RSRR 
data demonstrated that only some of the hospitals had succeeded in doing so. 
METHODS 
Study design and sample 
 We chose a qualitative study design with hospital site visits and in-depth 
interviews with staff, as this method is well suited to characterizing organizational 
context and implementation processes [50]. We selected hospitals on the basis of 
improvement or deterioration in RSRR performance over the course of their first two 
years of participation in the STAAR initiative, operationalized as greater than 1 
percentage point increase or decrease in RSRR. RSRR was computed using the same 
calculation approach as that used by the Centers for Medicare & Medicaid Services 
(CMS) for public reporting of 30-day RSRR [70, 71]. We limited our sampling frame to 
hospitals that had enrolled in the STAAR initiative by July 1, 2010 (n=67) and excluded 
hospitals that were participating in a separate readmissions initiative called Hospital to 
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Home [72] at the same time (n=12) or lacked sufficient data to calculate RSRR (n=2). 
This provided a sampling frame of 53 hospitals (Figure 2.1).  
 
Figure 2.1. Hospital selection process 
 
 To avoid hospitals where RSRR change may have reflected regression to the 
mean, we excluded hospitals with 2010-11 RSRR in the lowest 10% (RSRR < 21.94%) 
and highest 10% (RSRR > 24.99%) (n=11). From the remaining 42 hospitals, we 
excluded hospitals with fewer than 50 beds as very small size might be expected to affect 
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which changes were feasible or effective. We then selected hospitals where RSRR either 
decreased by more than 1% (n=11) or increased by more than 1% (n=7) between 2010-11 
and 2011-12. Out of this group, we invited participation from the hospitals with the 
greatest RSRR changes from each of the three states involved in STAAR (MA, MI, WA) 
with the goal of obtaining representation across states. We recruited additional hospitals 
until we reached theoretical saturation, that is, when additional site visits did not yield 
new themes [73, 74]. This occurred after site visits to a total of 10 hospitals, 7 hospitals 
where RSRR had decreased and 3 hospitals where RSRR had increased. Before 
saturation was reached a total of 13 eligible hospitals were invited to participate and 3 (all 
high performers) declined due to lack of time for staff to be interviewed. 
Data Collection and Analysis 
 Site visits and interviews were conducted between April 2014 and October 2014. 
We contacted hospital senior executives, who identified key staff for interviews, which 
were 30-90 minutes in duration (discussion guide as Appendix 1). We used the constant 
comparative method [50, 73–76] for analysis, with an integrated approach to developing 
the code structure [75]. Each transcript was independently coded by a team of three 
experienced qualitative researchers with backgrounds in public health, social work, and 
health care management. Disagreements among coders were resolved through negotiated 
consensus. Recurrent themes of similarity and difference across hospitals were identified, 
and illustrative quotes were selected for use in reporting results. We used Atlas.ti version 
7.5 (Berlin, Germany). 
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RESULTS 
 A total of 10 hospitals were included in the study; hospitals varied in terms of 
size, teaching status, and RSRR performance change (Table 2.1). We conducted 
interviews with 82 diverse hospital staff members (range of 4 to 18 people per site) 
(Table 2.2). RSRR performance at 7 of the hospitals had improved, by a mean of 2.42 
percentage points (high performing), and RSRR performance at 3 of the hospitals had 
deteriorated, by a mean of 1.95 percentage points (low performing). 
 
Table 2.1. Description of study hospitals 
Hospital ID 
Number 
RSRR 
change 
No. of 
Beds 
Teaching 
Status 
Number of 
Interviewees 
1 Improved 200-300 Non-teaching 5 
2 Improved 500+ Teaching 7 
3 Improved 200-300 Teaching 5 
4 Deteriorated 100-200 Teaching 7 
5 Deteriorated  500+ Non-teaching 9 
6 Improved 100-200 Non-teaching 18 
7 Improved 100-200 Non-teaching 9 
8 Improved 100-200 Non-teaching 10 
9 Deteriorated 300-400 Non-teaching 4 
10 Improved 100-200 Non-teaching 8 
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Table 2.2. Roles of interviewees 
 	   Administration 23 Analyst 3 
Director / Manager 4 
President / Vice President / CMO/ CNO 8 
Leaders of Partner Organizations (SNFs, physician 
organizations, elder services) 8 
Case Management 12 
Analyst 1 
Case manager 2 
Director / Manager 9 
Nursing 12 
Nurse 9 
Director / Manager 3 
Nutrition, Pharmacy, Respiratory Care, Social Work 9 
Clinician 4 
Manager 5 
Physicians 14 
Emergency Medicine 1 
Geriatrics 1 
Hospital Medicine 6 
Palliative Care 2 
Primary Care 1 
Quality Improvement 3 
Quality Management 12 
Analyst 3 
Director / Manager 9 
  Total1 82 
1In addition to the 82 hospital staff, we also interviewed 8 state-level leaders of the 
STAAR initiative who were affiliated with state hospital associations or quality 
improvement organizations. The interviews with state-level leaders were not utilized in 
the present analysis although they provided background for our interpretation. 
 
The role of organizational context 
High performing hospitals invested in creating an organizational context that 
would facilitate readmissions reduction, emphasizing efforts to influence ways of 
working, relationships, perceptions, and norms as opposed to a narrow focus on tasks or 
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processes. Investment in changing organizational context was considerably lower at low 
performing hospitals. 
Approaches that acted upon organizational context fell into four categories (Table 
2.3). First, high performers reported more extensive efforts to improve collaboration 
across disciplinary boundaries within the hospital. Second, they also described linkages 
between the hospital and outside organizations (e.g., skilled nursing facilities). Third, 
participants at high performing hospitals also described deeper engagement in learning 
and problem solving activity related to readmissions. Finally, high performers described 
greater levels of senior leadership support for readmissions reduction efforts, with senior 
leaders depicting efforts to reduce readmission rates as useful for improving patient care 
overall. Each category is described in further detail below. 
Table 2.3. Approaches targeting organizational context – more prominent in high-
performing hospitals 
1. Improving collaboration across disciplinary boundaries within the hospital 
• Multidisciplinary rounds to improve communication about discharge 
planning 
• Readmissions quality improvement teams bringing together different 
departments 
 
2. Improving collaboration with external organizations serving patients post-
hospitalization (SNFs, PCPs, social service organizations, etc.) 
• Regular meetings with post-acute providers to share readmissions data and 
problem solve 
• Direct patient hand-offs and joint quality improvement projects with SNFs 
 
3. Learning and problem solving related to readmissions 
• Application of learning and quality improvement techniques 
• Engagement with STAAR initiative 
 
4. Senior leadership support for readmissions reduction efforts 
• Emphasis on readmissions reduction as a mechanism to improve patient care 
• Directing additional resources to readmissions reduction 
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Working across disciplinary boundaries 
 Efforts to improve collaboration across disciplinary and departmental boundaries 
within the hospital were described as more extensive by interviewees at high performing 
hospitals, whereas low performing hospitals reported barriers to collaboration. To 
facilitate effective communication around discharge planning, participants from high 
performing hospitals reported dedicating substantial efforts to making multidisciplinary 
rounds run effectively. A physician in charge of quality improvement at a high 
performing hospital described investing in multidisciplinary rounds over a 2-year period:  
[We have] daily multi-disciplinary rounds in the inpatient units, where 
we’re really working hard to do careful coordinated discharge 
planning…absolutely every day.  They are attended by doctors, and 
nurses, and case managers, and social workers, and pharmacists, and 
physical therapists, and respiratory therapists, and occupational therapists.  
It’s a big gathering. They’re big and they’re powerful.” (Hospital 3) 
 
At some high performers, formal communication tools and mechanisms, such as patient 
rounds, were supported by organizational norms. A manager of social work at one high 
performing hospital described the sharing of information among disciplines as follows: 
We’re interacting all the time.  We’re going through things, so besides 
rounds, we may have multiple contacts throughout the day regarding 
different patients.  We can go to their office; they come in our office…The 
physicians aren’t set off to the side in the back behind a locked door doing 
their dictation… it’s very free access. (Hospital 8) 
 
In contrast, low performing hospitals tended to describe barriers to collaboration 
within the hospital. For example, at one low performing hospital, staff members with 
primary responsibility for implementing care transitions and readmissions reduction 
interventions were external contractors, which left them unable to access important 
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information. One care coordination contractor at this hospital explained: 
I just don’t always get to know what [my program’s readmission data] is. I 
mean, I’m sure my company gets to know what it is, but I don’t always get 
to see it. (Hospital 9) 
 
Low performing hospitals described communication across departments within the 
hospital as a challenge to readmissions reduction efforts. For example, a nutrition 
manager at one low performing hospital described difficulties posed by rigid 
departmental boundaries that impeded sharing feedback with physicians:   
I think one of the challenges can be if your [quality improvement] 
involves another department. I’m tracking if the dietitian has made a 
recommendation, does the doctor follow through on it. Then I’m like, 
“Who do I tell that to?” It’s gonna go through the [quality] committee…to 
the powers that be in the medical portion. (Hospital 4) 
 
Working across organizational boundaries 
Participants at high performing hospitals also described systematic approaches to 
collaboration with external organizations such as skilled nursing facilities (SNFs), 
primary care providers, and social service providers. One high performing hospital 
invited representatives of SNFs to participate in our study interviews, reflecting the 
strength of the relationships that had been formed through their work on readmissions. 
An SNF administrator described this engagement:  
Our hospital reached out to all of us and opened the doors for that dialog. 
When I think about the depth of our work together, it was a remarkable 
process. We got to know nurses here in the hospital. We listened to each 
other’s perspectives. The other thing is we could take it back to our skilled 
facilities…all of us went back to our medical directors and had these in-
depth dialogs about how can we reduce hospitalization? (Hospital 6) 
 
At another high performing hospital, collaboration between the hospital and local SNFs 
led to improved processes of care for heart failure patients within the SNFs, described by 
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this quality manager: 
We ended up going out [to the SNFs] and spent some time with them to 
understand their processes, their challenges.  With one of them we shared 
information that had worked for our heart failure patients and they 
established a heart failure clinic right within [the SNF] … That was a 
huge, huge help. (Hospital 1) 
 
 While attempts at collaboration with post-acute health care providers were 
mentioned by low performing hospitals, the relationships were described as less well 
developed. An administrator at one low performing hospital explained the hospital’s 
coordination with SNFs as a more bureaucratic designation of preferred providers rather 
than in-depth collaboration and joint problem solving: 
There was a group of us that sat down and said what do we want out of 
our preferred [SNF] providers? …. There was something that was 
developed by legal that then went out to the preferred providers. They 
signed it, we signed it. We put together … a PR thing that went out to the 
staff so that they knew the preferred providers … Then when we meet on a 
quarterly basis. If there [are] issues…or their metrics aren’t being reported 
then we discuss that.  (Hospital 9) 
 
Learning and problem solving related to readmissions 
 Participants at high performing hospitals emphasized the iterative nature of their 
work to reduce readmissions, describing extensive application of learning and quality 
improvement techniques to find the right approach for reducing readmissions within their 
particular organizational contexts. High performers reported many obstacles and failures 
in implementing readmissions reduction efforts, as did low performers. Yet, in contrast to 
low performers, interviewees at high performing hospitals treated failures as normal parts 
of the improvement process, and described routine use of techniques to leverage failure 
for learning. These techniques included sharing outcomes with and soliciting feedback 
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from staff, plan-do-study-act cycles (PDSA), small tests of change, and data collection to 
track progress. For example, an administrator at one high performing hospital described 
the iterative process that the hospital undertook to find interventions that would help 
high-risk patients manage their medications:  
[We use an] iterative process – if it's not working, why is it not working? 
Then what are you doing differently the following time to try something 
different? It's not just stopping and saying, okay, our hands are up here. 
It's always going back. Even when you got it right you still gotta go back 
and try something different to get it better. (Hospital 7) 
 
Interviewees at a number of high performers cited a general culture of learning 
and quality improvement at the hospital as supporting the specific learning and problem 
solving undertaken for readmissions reduction. A physician who managed a residency 
curriculum at one high performing hospital explained the underlying culture: 
This institution is really big on quality improvement. The culture of the 
institution is a lot of PDSA:  trying something out, if it doesn’t work, let’s 
understand why; let’s try a second round. It’s over and over again. I think 
that’s built into the institution quite a bit. (Hospital 2) 
 
In contrast to the high performing hospitals, where interviewees depicted flexible 
learning and problem solving approaches as integral to readmissions work, interviewees 
at low performing hospitals did not emphasize learning and problem solving techniques. 
Furthermore, some low performing hospitals described structural challenges to quality 
improvement. For example, this nurse manager described how constant turnover of 
physicians in one area made it difficult to implement new processes to reduce 
readmissions: 
It’s a little harder with one of the variables being that the docs are 
changing every two weeks… we want to create an instant team for them, 
but that’s hard when literally they’re only gonna be here for two 
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weeks…By the time they get it half way straight, the two weeks is over. 
(Hospital 4)  
 
Senior leadership support for readmissions reduction efforts 
 At high performing hospitals, interviewees referred to strong support from senior 
leadership for readmissions reduction efforts; this support shared two features. Leaders 
projected a sense that the hospital was concerned with reducing readmissions in order to 
improve patient care, which seemed to inspire clinicians, rather than just to avoid 
Medicare financial penalties; and leaders helped direct additional resources to 
readmissions reduction interventions. An administrator at one high performing hospital 
described senior level support for a constellation of readmissions initiatives undertaken at 
the hospital: 
The effort was supported from the top. … The President fully supported 
this effort on readmissions and it just happened. People really understood 
and embraced it at every level.  The process was not viewed as an optional 
choice. (Hospital 10) 
 
A physician chief at another high performing hospital cited senior leadership support – 
including instilling a perception that reducing readmissions would benefit patients – in 
helping to establish an active readmissions quality improvement committee.  
I guess you need to have an executive sponsor—and we've had two or 
three along the way…There's a feeling that we don’t want to balance our 
books on the backs of unnecessary readmissions, which is a pretty 
progressive stance for an institution that is having financial problems. 
(Hospital 3) 
 
Although low performing hospitals had implemented a number of readmissions 
reduction interventions, commitment from senior leadership was not emphasized by 
interviewees at those hospitals. They reported that after Medicare readmissions penalties 
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went into force, managers elevated the priority of readmissions reduction but at all three 
low performers, the directive to improve readmissions performance was driven in part by 
pressure from an umbrella system overseeing the hospital. One low performing hospital 
had made early interventions on readmission but these fell apart after the hospital was 
acquired by a new owner that did not initially prioritize readmissions reduction, as 
described by a physician administrator: 
We were making progress before, but then everything changed hands.  
Things got dropped. Now we seem like we’re seeing the stability and 
we’ve already got those processes which [staff] knew before, but you 
started over.  … Now everybody’s more willing to make those changes.  
The penalties that finally hit helped a lot too, right [laughs]? (Hospital 5) 
 
In-hospital practices targeting clinical processes   
Unlike the approaches targeting organizational context, no appreciable difference was 
observed between high performing hospitals and low performing hospitals in reported use 
of in-hospital practices targeting clinical processes (Table 2.4). A physician at one high 
performer described the hospital team coming to the realization that reducing 
readmissions required the hospital to go further than implementing these practices: 
It felt like if these [recommended practices] were the answers, that every 
time a patient was readmitted we should be able to refer to which pillar we 
didn’t get right. It just never seemed to simplify down that easily.  We 
arranged the follow up appointment.  They have all their paperwork.  They 
have their meds.  They still got readmitted... (Hospital 2) 
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Table 2.4. Changes to in-hospital clinical practices – did not vary by performance 
 # hospitals applying practice 
In-hospital clinical practices RSRR improved 
(n=7) 
RSRR deteriorated 
(n=3) 
Follow up appointments at discharge 6 / 7 3 / 3 
Medication management 5 / 7 2 / 3 
Phone call after discharge 6 / 7 2 / 3 
Risk of readmission / using in care 4 / 7 2 / 3 
Patient education / teach-back 6 / 7 3 / 3 	  
DISCUSSION 
 We identified four approaches to readmissions reduction that distinguished 
hospitals where performance on readmissions had improved from hospitals where 
performance on readmissions had deteriorated. These approaches targeted the 
organizational context for readmissions reduction as well as specific clinical 
improvement practices, including focused efforts to improve collaboration across 
disciplinary and organizational boundaries, deep engagement in learning and problem 
solving related to readmissions, and committed support from senior leaders. High 
performing and low performing hospitals had made many of the same changes to clinical 
processes – including follow up appointments before discharge, phone calls after 
discharge, medication management, risk stratification and patient education – suggesting 
that these changes alone were insufficient to reduce readmissions. This finding is 
consistent with the accumulated evidence on readmissions, which shows variable 
linkages between particular changes in clinical practice and readmissions reduction [53, 
55]; it also accords with evidence that hospitals exhibit similar readmissions performance 
across different conditions [77, 78] in a pattern consistent with the action of organization-
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level factors [79]. It seems likely that changes to clinical practice are efficacious in 
certain circumstances, but deploying them effectively also requires attention to the 
hospital’s organizational context. This could result from the organizational context 
mediating how well the clinical practice changes are implemented, or the organizational 
context influencing other work patterns within the hospital.  
 The contextual factors targeted by high performing hospitals in our study have 
been previously associated with improvement in hospital outcomes including 
readmissions. Coordination within the hospital has been linked with a range of 
performance indicators [68, 80, 81] and collaboration between hospitals and post-acute 
care providers has been recognized as important for preventing readmissions [82]. 
Learning and problem solving  techniques have also been linked to hospital performance 
improvement on other outcomes [83, 84] as has senior leadership support [85–89]. 
Although the importance of such organizational factors has been well recognized, the 
difficulty of changing organizational features such as culture and context is also well 
known [90–92]. Our results offer several specific approaches that successful hospitals 
have used to foster an organizational context conducive to readmissions reduction. 
There are several limitations to our study. First, the hospitals where readmissions 
performance had deteriorated made available fewer people for us to interview than 
hospitals where performance had improved. Low performing hospitals tended to have 
smaller networks of people engaged in readmissions reduction efforts, consistent with the 
lower emphasis on fostering coordination among disciplines and departments as part of 
their readmissions reduction efforts. Second, we were only able to examine readmissions 
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reduction strategies that were discussed by interviewees at our participating hospitals. 
While we were able to collect data on most of the clinical practice changes commonly 
recommended for readmissions reduction, and interviewers consistently probed for 
practice changes as well as contextual factors that might have affected implementation, it 
is possible that additional factors that did not come up regularly in our interviews also 
play a role in readmissions reduction. Third, the effectiveness of approaches targeting 
organizational context for readmissions may depend on some level of pre-existing 
organizational capacity, for example, a culture of effective communication to help work 
across disciplinary and organizational boundaries, or general skill in quality improvement 
techniques. Even if this is the case, our results can still be useful in pointing out domains 
in which hospital capacity strengthening could foster readmissions reduction. Finally, we 
selected hospitals on the basis of RSRR for heart failure; performance for other 
conditions might vary, although evidence shows that readmissions performance is 
generally consistent across conditions [77, 78]. 
In conclusion, our findings highlight several approaches that hospitals may be 
able to use to enhance the effectiveness of their readmissions reduction efforts, all of 
which target organizational context as opposed to particular clinical practices. Hospitals 
in our study were selected on the basis of changes in readmission rates over time, as 
opposed to level of performance, which allowed us to make an in-depth examination of 
what each hospital had done to influence change in readmissions. It appears that adoption 
of the types of clinical practices that have been widely studied and recommended for 
readmissions reduction are not sufficient to achieve desired results in all hospitals. As has 
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been recognized with other outcomes [39, 41–43, 66–68], the organizational context in 
which clinical practice changes occur plays an important role in readmissions and we 
have identified several specific changes to organizational context associated with success. 
Given questions that have been raised about the cost-effectiveness of focusing hospital 
resources on readmission reduction [93], it is useful to note that the approaches which 
appeared to facilitate readmissions reduction in our sample could support generalized 
hospital quality improvements as well.  
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CHAPTER THREE. INTEGRATING NEW PRACTICES:   
HOW HOSPITAL INNOVATIONS BECOME ROUTINE 
Introduction  
 Health care policy-makers, clinicians, and managers invest substantial time and 
resources on hospital quality improvement efforts, but many organizations fail to 
integrate new practices into organizational routines [94–97]. Lack of integration, that is, 
the embedding of new practices into organizational routines, undermines the potential to 
sustain the new practices [98, 99]. Within the field of health services research, several 
well-developed models have identified factors affecting implementation of new practices 
[86, 100] and recent theoretical work [97, 101–103] has highlighted the need to 
understand integration as a distinct and important feature of the implementation process. 
This stream of work in health services research supplements theory on absorptive 
capacity from the general management literature, which identifies an organization’s 
capacity to integrate new knowledge as a distinct ability [104–106] and posits a 
“routinizing” phase [107] during which integration takes place. 
Despite the presence of this theoretical literature, we have limited knowledge 
about the mechanisms by which integration occurs, as a paucity of empirical studies have 
focused on the integration of new practices into organizational routines. The influential 
review by Greenhalgh and colleagues (2004) [86] cited a gap in research on “the process 
leading to long-term routinization” of innovations, but little evidence on this topic has 
emerged in the intervening years. The few existing studies have described factors that 
appear to facilitate integration, including visible improvements in outcomes [108, 109], 
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organizational commitment signaled by champions with authority [98, 108, 110], and 
continuity of key personnel who can train others [108]. Although it is helpful to identify 
these facilitating factors, we lack an in-depth understanding of the dynamic processes that 
constitute integration, which would provide stronger foundation for applying knowledge 
about facilitators in practice. Furthermore, the existing findings on integration derive 
largely from case studies of a handful of sites [98, 109, 110] or implementing a single 
intervention [98, 108].  
Accordingly, we sought to examine the process of integrating newly adopted 
practices into routine standard operating procedures. We focused on hospital efforts to 
reduce unplanned readmission rates as this has become a national priority. We selected a 
qualitative study design with site visits and in-depth interviews because this method is 
well-suited for understanding experiences in rich detail, particularly those that may 
involve nuanced issues of organizational culture and group dynamics [50]. We examined 
experiences of integrating new practices in 10 hospitals participating in the State Action 
on Avoidable Rehospitalizations (STAAR) initiative [69], selecting hospitals where 
readmissions performance had either improved or deteriorated. All of the readmissions 
reduction practices examined as part of our study are supported by published evidence of 
efficacy [56–65], although the effectiveness of these practices appears to depend upon 
implementation and context [53, 55]. Findings from our study may be used to improve 
the design of national efforts to promote not only the adoption but also the integration of 
evidence-based practices into hospital routines. 
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Methods 
Study design and Sample 
We conducted a qualitative study [50, 74] of hospitals that participated in the 
STAAR initiative, which operated from 2009 to 2013 in Massachusetts, Michigan and 
Washington [69]. To be eligible for the present study, hospitals had to have enrolled in 
the STAAR initiative by July 1, 2010 (n=67). As illustrated in Figure 3.1, we excluded 
hospitals that were participating in a different readmissions collaborative at the same time 
(the Hospital to Home initiative, n=12) or did not have sufficient data to calculate a risk-
standardized readmission rate (RSRR) for heart failure (n=2), resulting in a sampling 
frame of 53 hospitals. RSRR was computed with the same approach as that used by the 
Centers for Medicare & Medicaid Services (CMS) for public reporting of 30-day RSRR, 
except using one year of data instead of three [70, 71].  	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Figure 3.1. Hospital selection process 
 
Diagram of hospital selection process. 
 
To facilitate data collection on integration of readmissions reduction practices as 
well as the converse, we selected from the sampling frame hospitals where readmissions 
performance had either improved or deteriorated, operationalized as greater than 1 
percentage point change between July 2010-June 2011 and July 2011-June 2012, 
representing the first two years of the STAAR initiative. We excluded hospitals with 
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2010-11 RSRR in the lowest 10% (RSRR <21.94%) and highest 10% (RSRR >24.99%) 
(n=11) to avoid hospitals in which RSRR change may have reflected regression to the 
mean. From the remaining 42 hospitals, we excluded hospitals with fewer than 50 beds – 
as they would likely lack sufficient volume to develop the types of routines that could be 
seen in larger institutions – and then selected hospitals where RSRR either decreased by 
more than 1% (n=11) or increased by more than 1% (n=8) between 2010-11 and 2011-12. 
From this sample, we invited participation from the hospitals with the greatest changes in 
the positive and negative directions from each of the three states (MA, MI and WA) with 
the goal of obtaining representation across states. We continued recruiting hospitals until 
reaching theoretical saturation, i.e., when no new information emerged from additional 
sites [73, 74]. We conducted visits and interviews at a total of 10 hospitals. Of 13 eligible 
hospitals invited to participate, 3 declined. We also interviewed 8 members of state-level 
STAAR leadership teams, including 3 from MA, 3 from MI and 2 from WA. These state-
level leaders were generally affiliated with state hospital associations or similar 
organizations. 
Data Collection and Analysis 
 Site visits and interviews took place from April – October 2014. At each hospital, 
2-3 experienced qualitative interviewers with backgrounds in public health, social work, 
nursing, management and medicine conducted in-depth interviews with key staff 
involved with efforts to reduce readmissions and the STAAR initiative. A coordinator at 
each hospital, who was nominated by a senior executive such as the President or Chief 
Executive Officer, identified the key staff. Individual interviews were requested but due 
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to participant preferences or scheduling constraints, some interviews included 2 or more 
interviewees. A semi-structured interview guide with probes was used to ensure 
consistency. Interviewees were asked to describe the practices that their hospitals had 
implemented as part of efforts to reduce readmissions, to detail which if any of those 
practices had become integrated into routine operations, and to explain how the process 
of integration had proceeded. Interviews were recorded and professionally transcribed, 
with the exception of one hospital where we were asked not to record and 2 researchers 
took detailed notes during the interviews. All research procedures were approved by the 
Yale University Institutional Review Board.  
 We employed the constant comparative method of qualitative data analysis [50, 
73–76] with line-by-line coding and identification of key themes. Coding and analysis 
were conducted in parallel with site visits so that we could continue site visits until 
theoretical saturation. An integrated approach [75] was used to develop the code 
structure, drawing on recurrent themes that emerged from the data as well as the theory 
underlying the project. A team of three experienced qualitative researchers, including 
members with backgrounds in public health, social work and management, independently 
coded every transcript. The codes were expanded, refined and merged as further 
transcripts were coded until a final code structure stabilized. At this point, the final code 
structure was applied to all previously reviewed transcripts and was used for successive 
transcripts. Disagreement among coders was resolved through discussion, although 
agreement was generally high. ATLAS.ti version 7.5 (Berlin, Germany) was used for all 
coding and organization of data. 
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Results 
Sample characteristics 
We interviewed a total of 90 individuals including 82 hospital staff and 8 
representatives of state hospital associations or quality improvement organizations 
involved in the STAAR initiative (Table 3.1). Interviewees from the 10 hospitals 
represented a range of positions, including clinicians (physicians, nurses, social workers, 
dieticians and therapists), care coordinators, managers and senior executives (Table 3.2). 
Thematic saturation was reached after site visits to 7 hospitals where RSRR performance 
improved and to 3 hospitals where RSRR performance deteriorated. Examples of 
successful as well as unsuccessful integration were present at both types of hospitals.  
 
Table 3.1. Description of study hospitals 
Hospital ID 
Number 
No. of 
Beds 
Teaching 
Status 
Number of 
Interviewees 
1 200-300 Non-teaching 5 
2 500+ Teaching 7 
3 200-300 Teaching 5 
4 100-200 Teaching 7 
5 500+ Non-teaching 9 
6 100-200 Non-teaching 18 
7 100-200 Non-teaching 9 
8 100-200 Non-teaching 10 
9 300-400 Non-teaching 4 
10 100-200 Non-teaching 8 
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Table 3.2. Roles of staff interviewees 
Administration 23 
Analyst 3 
Director / Manager 4 
President / Vice President / CMO/ CNO 8 
Leaders of Partner Organizations (SNFs, physician 
organizations, elder services) 8 
Case Management 12 
Analyst 1 
Case manager 2 
Director / Manager 9 
Nursing 12 
Nurse 9 
Director / Manager 3 
Nutrition, Pharmacy, Respiratory Care, Social Work 9 
Clinician 4 
Manager 5 
Physicians 14 
Emergency Medicine 1 
Geriatrics 1 
Hospital Medicine 6 
Palliative Care 2 
Primary Care 1 
Quality Improvement 3 
Quality Management 12 
Analyst 3 
Director / Manager 9 
State hospital associations and QIOs 
 Staff 8 
  Total 90 
 
A consistent pattern of successful integration 
 Participants explained the process of integrating a variety of evidence-based 
readmissions reduction innovations, which are listed in Table 3.3. Across these diverse 
practices and different hospitals, a consistent pattern emerged across examples of 
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successful integration. When integration was successful, participants reported that after a 
practice had been introduced and implemented, a small number of key staff (in some 
cases a single person) continued to devote substantial effort to holding the innovation in 
place for as long as a year while more permanent integrating mechanisms began to work 
(Figure 2). One physician who was leading efforts to reduce unplanned readmissions 
described this extended holding as follows: 
It’s just steady commitment—I think one of the things that goes wrong in 
change projects is that people give up.  If you don’t give up, it eventually 
sticks. (Hospital 3)   
 
Similarly, in describing the integration of bedside multidisciplinary care 
conferences into a routine practice, a quality manager characterized her own role holding 
the new process in place until it became routine:  
For six months, [we] attended every care conference… that was a big 
dedication… every single day for six months...  After that, we did about 
three months where it was a random [check]. As they were in the rooms, 
we would stand outside in the hallway. We had a little checklist, and they 
knew what we were looking for, but after that, it stuck. [Now] they do the 
rounds and they have to document it. (Hospital 1) 
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Table 3.3.  Characteristics of Readmissions Reduction Innovations 
Readmissions reduction innovation 
Intrinsic 
reward to staff 
Integrating 
mechanisms observed 
1. Patient education [57, 61] High Shifts of attitudes and 
norms 
2. Follow up phone calls to patients 
after discharge [57, 59–61] 
High Shifts of attitudes and 
norms 
3. Discharge planning 
(multidisciplinary rounds to 
coordinate) [60, 61, 111] 
High Shifts of attitudes and 
norms 
4. Collaboration with post-acute 
providers (e.g., SNFs) [63] 
High Shifts of attitudes and 
norms 
5. Scheduling follow up appointments 
before discharge [59, 60] 
Low Changed incentives 
6. Medication management [59, 60] Low Changed incentives 
7. Flu and pneumonia vaccination for 
indicated patients [112, 113] 
Low Automation 
 
 
Figure 3.2. Level of dedicated effort changes over the course of integrating an 
innovation 
 
During the process of integration, the innovation is held in place for an extended period 
while integrating mechanisms take effect. 
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Effective integrating mechanisms 
The readmissions reduction innovations examined in our study were process 
changes requiring new behavior by staff, so integration relied on individuals continuing 
to perform the new behavior after external pressure maintaining the innovation abated. 
Likewise, individuals could impede integration through passive or active resistance.  
We observed three prominent categories of integrating mechanisms that took over the 
role of key staff holding new practices in place:  shifts of attitudes and norms, changed 
incentives, and automation. The integrating mechanisms responsible for enabling 
integration of particular practices varied according to whether staff found the new 
practice intrinsically rewarding (Table 3.3). If staff members experienced direct benefits 
– for example, improved job satisfaction from seeing patient outcomes improve – 
individual attitudes and group norms were effective integrating mechanisms. In contrast, 
for new practices in which staff did not perceive benefits to themselves or their group, 
incentives and system change through automaton were applied as effective integrating 
mechanisms.  
New practice provides intrinsic reward to staff. In situations where new practices 
were rewarding to staff, attitudes and norms became effective integrating mechanisms as 
they changed over time. Such changes were observed for several innovations including 
one-on-one patient education, follow-up phone calls with patients after discharge, 
multidisciplinary rounds to coordinate care for specific patients and prepare for 
discharge, and collaboration with post-acute providers such as skilled nursing facilities 
(SNFs) to coordinate care transitions. For each of these, however, it was difficult for staff 
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to recognize the benefits of an innovation immediately. Typically this required the 
accretion of first-hand evidence over at least several months, which eventually changed 
participants’ attitudes and convinced them to self-reinforce the new practice.  
Most often the benefits experienced by staff involved enhanced job satisfaction 
from directly seeing patient outcomes improve, but benefits also included more 
predictable work flows and more interesting work. A Chief of Hospital Medicine 
described how nurses gradually embraced a new responsibility for making follow up 
phone calls after discharge, as nurses benefited from feeling greater professionalism and 
satisfaction with their work:  
…when it was first implemented, I went around to every clinic to tell them 
about this, and you can imagine the reception I got initially about doing 
more work. Then it was really exciting because after doing it for a little 
while, the [nurses] realized that it was really exciting. It's nursing work at 
its best… I mean it's really using nurses at the top of their license. They 
recognized it, and they all had anecdotal stories to tell about how their 
calls really made a difference, helped people. That's been great because it's 
really become a good fit. For the nurses, it's obviously required some 
shifting of their responsibilities, but they've been able to do that. That's 
something that's become integrated into the system. (Hospital 3) 
 
In another example, it took time for staff to realize that bedside rounds were actually 
saving them time, but once this realization set in, staff performed the rounds regularly 
without complaint. As a department manager described:  
[The managers] said, "This will work.  Just give us time."  Over time [the 
staff] said, "Wow, we're spending a half an hour less time on our patients.  
We love it." (Hospital 7) 
 
A similar pattern emerged in another hospital in which staff at first had to overcome 
several barriers to implementing multidisciplinary rounds, including scheduling 
difficulties and staggered staffing assignments; however, as staff experienced benefits, 
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they became willing to make the adjustments needed to attend and the new practice 
became integrated, as described by a quality advisor: 
There have been a lot of obstacles.  I think that the more benefit the 
clinicians see to themselves, the more adaptability there is. People are 
willing to say, “Okay, yeah. I should go up [to multidisciplinary rounds] 
now, because this will help me with my discharges later in the day.” 
(Hospital 3) 
 
In several cases, the benefits staff came to understand accrued not only to 
themselves but also to their patients, as reported by a director of case management who 
oversaw innovations in care transitions. She noted the importance of staff gratification in 
seeing improved patient outcomes, which she termed “hooray moments,” and noted these 
realizations caused staff to self-reinforce readmissions reduction interventions: 
I think when people can watch progress or success through readmission 
reduction and you get those hooray moments, people want to keep 
reinforcing that… (Hospital 6) 
 
Highlighting the motivating power of benefits to patients, one quality manager contrasted 
teach-back patient education practices, which were easier to integrate, with making 
follow-up appointments, which were more difficult to integrate: 
I think that teach back [appeals to nurses] because nurses have gone into 
nursing because they want to be able to help patients out. [With teach 
back] they’re right there with the patient. They’re able to have that hands-
on care with them and develop that relationship, whereas follow-up 
appointments are a clerical thing. They’re not seeing what impact [the 
follow up appointment] is having on … their patient. (Hospital 1) 
 
An important factor in changing attitudes and norms and convincing staff to 
internalize a behavior change was observing sustained management commitment over 
time, particularly in light of constantly fluctuating procedures. In successful cases of 
integration, the innovation was maintained initially by the urging and problem solving of 
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committed, key staff, and only over time did it become apparent that the hospital was not 
going to abort the practice. Interviewees reported that a history of abandoned change 
projects left staff doubtful, as noted by a chief of emergency medicine in reference to 
difficulties faced by that hospital’s readmissions reduction team:  
…There's just the natural skepticism that the goalposts are continuously 
moving.  Doesn't matter what you do. It's gonna change six months from 
now. The measures are gonna change. The requirements are gonna 
change… or the measure will just disappear.  We struggle with that. 
(Hospital 7) 
 
Thus, seeing the institution maintain commitment to an innovation over time 
helped convince staff to continue the new behavior on their own. A respiratory care 
manager described the process of overcoming staff skepticism to integrate a new 
approach to educating patients with chronic obstructive pulmonary disease (COPD) 
before discharge: 
It was a big change for my staff; they were so not used to doing this. I had 
to…keep pushing them. A couple times I heard, “Yeah, don’t worry, this 
will go away.”…I said, “This is the right thing to do for the patient … I 
said, “This is not going away”… I think when people realized how serious 
we were about it, they got on board.  It was persistence.  I just had to keep 
going.  (Hospital 7) 
 
Once most of the existing staff had begun self-reinforcing an innovation, changed 
norms – propagated by training and socialization systems – in some cases supplanted the 
need to change individual attitudes. A quality manager described how the incorporation 
of teach back patient education techniques into the nurse training program had made it a 
default behavior for incoming personnel: 
Interviewer:  How is it different now from when you were initially getting 
people to understand the concept of teach back…in the first year or so?  
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Interviewee:  I think that because most of our new graduate nurses come 
from our local community college, and because we work with [the 
college] up front, this is something we’re expecting. The [new grads] have 
that part. They just know what teach back is. (Hospital 1) 
 
Physicians also remarked how their group norms shifted over time, particularly pertaining 
to care transitions. New physicians were now being trained to attend to plans for care 
transitions as patients approached discharge: 
For the hospitalists and the inpatient residents, we've been talking about 
[readmissions reduction and care transitions] now for five years and I 
think that it's just the way they have learned to [practice]. You know, you 
have three years of residents and each resident comes through, and they 
hear the same concern.  Plus you hear about it everywhere. (Hospital 2) 
 
New practice is not intrinsically rewarding to staff. When staff failed to 
experience benefits from an innovation, the mechanisms involved in integration relied on 
constructing systems that either incentivized or forced the behavior required for the new 
practice. For example, providing patients with prescription medication before they left 
the hospital and scheduling follow up appointments before discharge were two 
innovations that staff did not find intrinsically rewarding. These tasks were not 
considered particularly enjoyable and the impacts on patients were too far removed to 
influence job satisfaction. In such cases, accountability systems to incentivize compliance 
were effective for integrating the new practice into routine operations, as described by 
one hospital executive: 
I think holding the nurse managers…[and] case management accountable, 
for what they’re doing and what they’re not doing also. Because if they 
know nobody’s watching, well, it’s just like your kids. [Chuckling]  
They’re gonna push the envelope in certain directions.  (Hospital 5) 
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Entering orders for flu and pneumonia vaccination for eligible patients was 
another intervention that was not seen as intrinsically rewarding by staff and whose 
benefits to patients were not directly observed by staff. Hence, automation involving the 
hospital’s electronic medical record was designed to forced physicians to complete this 
practice, leading it to become integrated into routine, as described by a nurse manager: 
Flu and pneumonia vaccine was—we did a lot of quality improvement at 
the beginning and a lot of chasing people down when they hadn’t done 
were they were supposed to do … Then we went to [requiring them] to put 
the order in.  They weren’t putting the orders in. Then we went to 
attaching it to every order set. Now it is getting done 99 percent of the 
time. (Hospital 4) 
 
 In situations where innovations became integrated without providing direct 
gratification for staff, the integrating mechanism that held the new practice in place 
appeared to vary based on task complexity. When a task had low complexity, that is, 
when it was simple to determine if the task had been done properly (e.g., ordering a 
vaccination), automation could be used to integrate the new practice. When tasks were 
more complex, as with providing medication before discharge or scheduling follow-up 
appointments before discharge, interviewees tended to cite incentives as the integrating 
mechanism that led to routinizing the new practice. Innovations that became integrated 
through shifting attitudes and norms tended to involve complex tasks so we could not 
analyze whether integrating mechanisms in this category varied according to task 
complexity. Figure 3.3 illustrates how integrating mechanisms tended to correspond to 
staff gratification and task complexity. 	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Figure 3.3. Integrating mechanisms vary according to characteristics of an 
innovation 
 
When an innovation provided a high level of intrinsic reward to staff, shifts of attitudes 
and norms were the integrating mechanisms that held the new practice in place. When 
the level of intrinsic reward provided to staff was low, changed incentives and 
automation held the innovation in place, depending on task complexity. 
 
 
We encountered two situations where hospitals reported the use of integrating 
mechanisms in a way that deviated from this pattern and a mismatch between integrating 
mechanism and innovation complexity appeared to undermine the effectiveness of the 
innovation. Interviewees at these two hospitals reported having used an automated 
function of the electronic medical record (EMR) to integrate new processes for pre-
discharge patient education, which is a complex task that can be done well or poorly. 
Other hospitals that successfully integrated new practices for patient education had 
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described changing staff attitudes and group norms as the primary integrating 
mechanisms; education at these hospitals emphasized teach-back and conversation 
between patient and caregiver. In contrast, the pre-discharge education at hospitals that 
reported using automation to integrate patient education lacked interaction between 
patient and caregiver. A manager at one of the hospitals reporting a reliance on 
automation to integrate patient education described the patient education process as "a 
bunch of education that comes flying out [of the printer]” for the patient to read, without 
a face-to-face component. Both of the hospitals that reported patient education integrated 
through automation had experienced deterioration in their RSRR performance. Although 
our data does not allow us to make a causal link, this finding highlights a risk that relying 
too heavily on EMR automation to integrate new practices may tempt hospitals to over-
simplify process innovations.  
Discussion 
 We found evidence of three distinct integrating mechanisms that transformed 
innovations from practices imposed on a hospital organizational system to habits that 
were reinforced by the system. These integrating mechanisms – shifts of attitudes and 
norms, changed incentives, and automation – required time to unfold, creating a need for 
one or more key individuals to hold the innovation in place beyond implementation. This 
process was comparable to holding the innovation in place until the glue attaching it to 
the organization dried. Previous studies on implementing innovations have recognized an 
important role for individual proponents of change [86, 100]; our findings provide further 
nuance about the function of such individuals in integration and can inform hospitals in 
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planning resources and timelines for implementation of new practices. Our findings also 
show integration occurring as a discrete set of activities, linked to initial implementation 
but not entirely the same. This provides empirical support for prior theories, such as 
Rogers’ diffusion of innovation model [107] and the AIDED model of health innovation 
spread [101, 114], which posited a distinctive phase after implementation when 
innovations become integrated.  
The integrating mechanisms experienced by participants in our study were 
described as being effective for innovations with particular characteristics. After being 
held in place, new practices that proved intrinsically rewarding for staff tended to 
integrate through self-reinforcement of a new practice, which often led to changed group 
norms that were propagated through training and socialization. Innovations whose 
benefits were not directly perceived by staff were integrated using incentives or 
automation. Our interviews identified a wider range of innovations that had successfully 
integrated through shifting attitudes and norms as staff experienced benefits to 
themselves or patients. This could indicate that innovations with direct benefits to staff 
more easily integrate, or that process innovations to reduce readmissions tend to produce 
visible benefits for staff. Despite the prominent role of improved patient outcomes 
directly observed by staff, which proved gratifying, it was notable that generalizable 
evidence of an innovation’s efficacy did not emerge as a prominent factor explaining 
integration success. Although all of the interventions analyzed for our study did have 
documented evidence of efficacy, interviewees did not cite evidence in explaining 
successful integration.  
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Our findings on integration focus on the continuation of new behaviors by staff, 
as this was constitutive of integration for the process innovations documented in our 
study. The integrating mechanisms that we identified as leading staff to self-reinforce 
new behaviors are consistent with the widely applied Theory of Planned Behavior [115]. 
This theory posits that performance of a behavior is influenced by an individual’s attitude 
toward the behavior, subjective norms, and perceived behavioral control. Shifting 
attitudes and norms emerged as integrating mechanisms in our results, specifically for 
innovations with benefits experienced directly by staff. Observing the benefits of 
performing a new practice can also affect perceived behavioral control, also known as 
self-efficacy [116]; staff learn that they can effect positive results through performing the 
innovation, which enhances their intentions to repeat the behavior in the future. When 
staff failed to benefit from an innovation, managers could link the new practice to a set of 
sanctions or rewards as an alternative route to influence attitudes toward the behavior and 
possibly subjective norms. The integrating mechanism of automation decoupled an 
innovation from staff behavior, avoiding the need to influence staff attitudes and norms.   
  Findings from our study cohere with the depiction of integration provided by 
Normalization Process Theory (NPT) [117]. NPT emphasizes that the choices of human 
agents, through ‘cognitive participation’ and ‘collective action,’ are what drives practices 
to become embedded in social contexts [117]. Correspondingly, we found that staff 
appraisal of the impact of an innovation (similar to what NPT terms ‘reflexive 
monitoring’) proved instrumental in enlisting staff to reinforce the new practice, 
consistent with other innovation frameworks that have noted visibility of benefits and 
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adopters’ perspectives [86, 100]. Our results also point to an important dynamic in the 
integration of deliberately introduced innovations that was not explicitly addressed by 
NPT:  the transition of ownership from a key person who holds the innovation in place 
through intensive monitoring and admonitions, to staff participants who self-reinforce the 
innovation with minimal monitoring.  
 Several limitations should be considered in interpreting our results. First, all of the 
innovations described by participants in our study were process changes; results may 
differ when the innovation is a new technology, although new technologies often entail 
changes to work processes as well. Second, during our study period hospitals faced 
pressure to reduce readmissions rates due to the introduction of new Medicare 
requirements for public reporting and financial penalties for readmissions rates. The 
integration process may differ for innovations lacking such external pressure. Third, the 
hospitals participating in our study had enrolled in a quality improvement initiative to 
reduce readmissions, and therefore may have had above-average levels of interest and 
ability in integrating innovations. We believe that our sampling strategy of selecting 
hospitals that had improved as well as deteriorated in RSRR performance mitigated this 
issue. Last, our sample of hospitals was relatively small, although each hospital provided 
data on a range of different innovations which allowed us to analyze the integration of a 
larger number of innovations.   
Conclusions 
 In conclusion, our findings imply several opportunities for hospitals to enhance 
the integration of new practices. Truly integrating a new practice requires patience and 
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persistence; therefore, implementation plans that budget for the extended effort required 
to hold a new practice in place while integration occurs are likely to be more successful. 
Awareness of integrating mechanisms that correspond to different innovation 
characteristics may aid hospitals in developing strategies to foster the processes entailed 
in integration, to help innovations become sustained practice changes rather than “the 
flavor of the month,” as two of our study participants put it. In particular, staff members’ 
own desires to provide good patient care can be harnessed as a powerful tool to foster 
integration of innovations that improve patient outcomes. Allowing staff to see any 
positive impacts on patients can enlist them as partners in reinforcing the innovation. 
Fostering a culture that encourages staff to derive personal satisfaction from providing 
good patient care could also help. With evidence-based practices continually emerging, 
hospitals with the capacity to integrate innovation into routines will be best positioned to 
improve outcomes for patients. 	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